CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CIK 1100682
Ticker
CRL (NYSE)
Industry
Services-Commercial Physical & Biological Research
Headquarters
Wilmington, MA 01887
Fiscal year end
2025 (FY)
Market Data
Close
$302.20
Change
+$0.07
Change %
0.02%
Volume
30,436
CRL · trading date Oct 12, 2026 · previous close $302.13 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$4.02B
Net income
-$144.34M
Total assets
$7.14B
Total liabilities
$3.92B
Stockholders' equity
$3.16B
Cash & equivalents
$213.77M
Operating income
$25.16M
Operating cash flow
$737.65M
Capital expenditures
$219.15M
Fiscal year 2025, via 10-K filed 2026-02-18.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
0.6%
Net margin
-3.6%
Free cash flow
$518.49M
Free cash flow margin
12.9%
Liabilities / assets
55.0%
Equity / assets
44.4%
CapEx / revenue
5.5%
Operating cash flow / net income
-5.11×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Wilmington, MA 01887
251 BALLARDVALE ST
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.